These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 10403908)
1. Impaired expression of MHC class II molecules in response to interferon-gamma (IFN-gamma) on human thymoma neoplastic epithelial cells. Inoue M; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Shirakura R; Matsuda H Clin Exp Immunol; 1999 Jul; 117(1):1-7. PubMed ID: 10403908 [TBL] [Abstract][Full Text] [Related]
2. Altered T cell development in human thymoma is related to impairment of MHC class II transactivator expression induced by interferon-gamma (IFN-gamma). Kadota Y; Okumura M; Miyoshi S; Kitagawa-Sakakida S; Inoue M; Shiono H; Maeda Y; Kinoshita T; Shirakura R; Matsuda H Clin Exp Immunol; 2000 Jul; 121(1):59-68. PubMed ID: 10886240 [TBL] [Abstract][Full Text] [Related]
3. T-cell development in human thymoma. Inoue M; Fujii Y; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Matsuda H Pathol Res Pract; 1999; 195(8):541-7. PubMed ID: 10483584 [TBL] [Abstract][Full Text] [Related]
4. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma. Ichikawa Y; Shimizu H; Yoshida M; Arimori S Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261 [TBL] [Abstract][Full Text] [Related]
5. Accumulation of immature CD3-CD4+CD8- single-positive cells that lack CD69 in epithelial cell tumors of the human thymus. Takeuchi Y; Fujii Y; Okumura M; Inada K; Nakahara K; Matsuda H Cell Immunol; 1995 Apr; 161(2):181-7. PubMed ID: 7697728 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of lymphoid cells in thymic epithelial neoplasms. Nakajima J; Takamoto S; Oka T; Tanaka M; Takeuchi E; Murakawa T Eur J Cardiothorac Surg; 2000 Sep; 18(3):287-92. PubMed ID: 10973537 [TBL] [Abstract][Full Text] [Related]
7. An immunohistologic study of the epithelial and lymphoid components of six thymomas. van der Kwast TH; van Vliet E; Cristen E; van Ewijk W; van der Heul RO Hum Pathol; 1985 Oct; 16(10):1001-8. PubMed ID: 2412943 [TBL] [Abstract][Full Text] [Related]
8. [Expression of CD20 in thymomas and its clinical implication]. Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589 [TBL] [Abstract][Full Text] [Related]
10. Neoplastic thymic epithelial cells of human thymoma support T cell development from CD4-CD8- cells to CD4+CD8+ cells in vitro. Inoue M; Fujii Y; Okumura M; Takeuchi Y; Shiono H; Miyoshi S; Matsuda H; Shirakura R Clin Exp Immunol; 1998 Jun; 112(3):419-26. PubMed ID: 9649210 [TBL] [Abstract][Full Text] [Related]
11. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms. Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864 [TBL] [Abstract][Full Text] [Related]
12. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Hoffacker V; Schultz A; Tiesinga JJ; Gold R; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A Blood; 2000 Dec; 96(12):3872-9. PubMed ID: 11090072 [TBL] [Abstract][Full Text] [Related]
13. Alterations of the immune system in thymic malignancies. Weksler B; Lu B J Thorac Oncol; 2014 Sep; 9(9 Suppl 2):S137-42. PubMed ID: 25396311 [TBL] [Abstract][Full Text] [Related]
14. Correlation of thymic pathology with HLA in myasthenia gravis. Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374 [TBL] [Abstract][Full Text] [Related]
15. Evidence for distinct mechanisms in the shaping of the CD4 T cell repertoire in histologically distinct myasthenia gravis-associated thymomas. Ströbel P; Helmreich M; Kalbacher H; Müller-Hermelink HK; Marx A Dev Immunol; 2001; 8(3-4):279-90. PubMed ID: 11785677 [TBL] [Abstract][Full Text] [Related]
16. Regulation of Th-POK and Runx3 in T cell development in human thymoma. Tokunaga T; Hayashi A; Kadota Y; Shiono H; Inoue M; Sawabata N; Okumura M Autoimmunity; 2009; 42(8):653-60. PubMed ID: 19886737 [TBL] [Abstract][Full Text] [Related]
17. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis. Okumura M; Fujii Y; Shiono H; Inoue M; Minami M; Utsumi T; Kadota Y; Sawa Y Gen Thorac Cardiovasc Surg; 2008 Apr; 56(4):143-50. PubMed ID: 18401674 [TBL] [Abstract][Full Text] [Related]
18. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells. Fujii Y; Hayakawa M; Inada K; Nakahara K Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007 [TBL] [Abstract][Full Text] [Related]
19. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma. Luther C; Poeschel S; Varga M; Melms A; Tolosa E J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045 [TBL] [Abstract][Full Text] [Related]
20. Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. Donia M; Andersen R; Kjeldsen JW; Fagone P; Munir S; Nicoletti F; Andersen MH; Thor Straten P; Svane IM Cancer Res; 2015 Sep; 75(18):3747-59. PubMed ID: 26183926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]